Safe administration of medications is a high priority worldwide. Avoidance of medication errors is critical to ensure a safe environment for our patients. The utilization of technology to support medication management has had positive impacts on patient safety and appropriate therapeutic selections.
Editorial
Safe administration of medications is a high priority worldwide. Avoidance of medication errors is critical to ensure a safe environment for our patients. The utilization of technology to support medication management has had positive impacts on patient safety and appropriate therapeutic selections. 1 Given the significant number of adverse drug events that are attributed to medication errors, it is essential that we take measures to improve patient safety especially regarding medication utilization. The use of computerized order entry, best practice advisory alerts, order sets, and order panels are only a handful of examples of how technology may assist in medication management. It is estimated that 56% of preventable adverse drug events occur during order entry and these reminders may guide providers in ordering appropriate ancillary fluids and/or medications that can reduce or manage adverse effects during drug therapy, in addition to ensuring safe and effective dosing. 2 One medication that may benefit from an order panel is amphotericin B: an antimicrobial that is used to treat invasive fungal infections. Amphotericin B is available as a deoxycholate salt and as a lipid-based or liposomal preparation. Although most are familiar with the high-alert and look-alike/sound-alike concerns with amphotericin B secondary to the Institute for Safe Medication Practices (ISMP) publications, this medication poses other significant risks as well. Amphotericin B has been associated with nephrotoxicity-the greatest risk seen with the deoxycholate salt formulation in comparison with the liposomal formulations. 3, 4 Anaphylactic-like and infusion reactions have also been reported with all formulations of amphotericin B. In addition, amphotericin B is incompatible with sodium chloride; therefore, it is important that this medication is not infused concomitantly with saline containing solutions. For providers and nurses that order and administer amphotericin B infrequently, it can be challenging to recall the recommended hydration and supportive medications that should be readily available at the time of amphotericin B administration, as well as the appropriate sequencing of these therapies.
To facilitate safe ordering and administration of amphotericin B, the University of Vermont Medical Center, a 562-bed rural, academic medical center in Burlington, Vermont, created an order panel for both the deoxycholate and liposomal formulations of amphotericin B available on formulary (Figure 1 ). The order panel was developed by pharmacy with nursing and physician input. The order panel consists of amphotericin B, a 0.9% sodium chloride 1000 mL intravenous solution, a 5% dextrose 50 mL piggy back, and an anaphylaxis kit that contains epinephrine, diphenhydramine, and methylprednisolone ( Figure 2 ). The 0.9% sodium chloride is used to prehydrate or "salt load" the patient as there are data to suggest that this may mitigate amphotericin B-induced nephrotoxicity through inhibition of tubuloglomerular feedback. 5 Therefore, it is common practice at our institution to administer a 0.9% sodium chloride bolus prior to each amphotericin B infusion for this salt loading effect. The volume is preset at 1000 mL; however, the ordering provider may adjust the volume if clinically indicated. A source of confusion we have observed is the use of 0.9% sodium chloride as a bolus prior to amphotericin B given that they are incompatible. A 5% dextrose 50 mL piggyback is made available to the nurse to flush the intravenous line following the 0.9% sodium chloride infusion and to clear the line after completion of the amphotericin B infusion to prevent precipitation within the intravenous line. The anaphylaxis kit is available in the event that any emergent adverse or anaphylactic effects arise during the infusion of amphotericin B. Preset administration instructions for the 0.9% sodium chloride intravenous solution, 5% dextrose 50 mL piggyback, and amphotericin B help guide the nurse on safe administration of amphotericin B as shown in Figures 3, 4 , and 5.
One benefit of the amphotericin B order panel is that it is comprised of all necessary medications with preset administration instructions to provide immediate educational guidance at the time of order entry and medication administration. This creates a safer environment, which will ultimately benefit the patient. We describe the use of an order panel specifically for amphotericin B; however, this approach may be safely and effectively applied to many other medications. As it can be difficult to recall recommendations for ancillary fluids and/or medications to mitigate adverse effects of infrequently ordered medications, the use of order panels may be most appropriate for high-risk, low-volume medications. Although high-risk, low-volume medications may vary from institution to institution, the concepts discussed here remain consistent and can be utilized at other centers. Our hope is to continue to improve patient care through various modalities and we encourage other facilities to adopt similar approaches to ensure a safe medication environment for our patients.
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